Cardinal Health Monoject, 3 mL Purple Enteral Syringe with Enfit Connection Sterile, REF 403SE

FDA Device Recall #Z-0859-2024 - Class I, December 28, 2023

Recall Summary

Recall Number Z-0859-2024
Classification Class I - Serious risk
Date Initiated December 28, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cardinal Health 200, LLC
Location Waukegan, IL
Product Type Devices

Product Description

Cardinal Health Monoject, 3 mL Purple Enteral Syringe with Enfit Connection Sterile, REF 403SE

Reason for Recall

Cardinal Health is expanding their previous product correction actions to a product removal of all sizes of Cardinal Health brand Monoject sterile Syringe Luer-Lock (1, 3, 6, 12, 20, 35, and 60 mL) and Cardinal Health brand Monoject sterile Enteral Syringes with the ENFit connection (1, 3, 6, 12, 35, and 60 mL) due to a change in manufacturing and rebranding efforts.

Distribution Pattern

Distribution US nationwide and Canada. Foreign distribution updated 9/6/2024 to only include Canada.

Lot / Code Information

UDI/DI 26971564466213 (Case), 16971564466216 (Box), 06971564466219 (Each), Lot Numbers: 230501, 230701, 230601

Other Recalls from Cardinal Health 200, LLC

Recall # Classification Product Date
Z-1768-2026 Class II Cardinal Health Monoject Tuberculin Syringe, 1 ... Feb 27, 2026
Z-1203-2026 Class II Chest Drainage Units and Accessories: Produc... Dec 26, 2025
Z-0897-2026 Class II ChemoPlus gowns: Product Code Product Descript... Nov 12, 2025
Z-0207-2026 Class II Salem Sump PVC Tubes: Product Code/Product N... Sep 18, 2025
Z-0208-2026 Class II Salem Sump PVC Tubes: Product Code/Product N... Sep 18, 2025

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.